✦ LIBER ✦

P.6.4 Salbutamol tolerability and efficacy in adult type III SMA patients: Results of a multicentric, molecular and clinical, double-blind, placebo-controlled study

✍ Scribed by Morandi, L.; Abiusi, E.; Pasanisi, M.B.; Lomastro, R.; Fiori, S.; Di Pietro, L.; Angelini, C.; Sorarù, G.; Gaiani, A.; Mongini, T.; Vercelli, L.; Vasco, G.; Vita, G.; Vita, G.L.; Messina, S.; Politano, L.; Passamano, L.; Gregorio, G. Di; Tiziano, F.D.

Book ID: 121085894
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 49 KB
Volume: 23
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2013.06.475

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of EPs 7630 in

Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitis : A randomized, double-blind, placebo-controlled clinical dose-finding study

✍ W Kamin; VG Maydannik; FA Malek; M Kieser 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

✍ Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Efficacy and Tolerability of a Red-vine-

Efficacy and Tolerability of a Red-vine-leaf Extract in Patients Suffering from Chronic Venous Insufficiency – Results of a Double-blind Placebo-controlled Study

✍ E. Rabe; M. Stücker; A. Esperester; E. Schäfer; B. Ottillinger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 490 KB

A phase III, double-blind, placebo-contr

A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (Natalizumab) in maintaining clinical response and remission in Crohn’s disease (ENACT-2)

✍ W. Sandborn; J.-F. Colombel; R. Enns; B. Feagan; S. Hanauer; I. Lawrance; R. Pan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Pharmacokinetic, pharmacodynamic, and to

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

✍ Paul Covington; Ronald Christopher; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Pharmacokinetics, Pharmacodynamics, and

Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study

✍ Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB